SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001655759-24-000052
Filing Date
2024-04-16
Accepted
2024-04-16 17:24:52
Documents
18
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A arvn-20240416.htm   iXBRL DEF 14A 881380
3 arvn-20240416_g1.jpg GRAPHIC 50501
4 arvn-20240416_g2.jpg GRAPHIC 17594
5 arvn-20240416_g3.jpg GRAPHIC 19983
6 arvn-20240416_g4.jpg GRAPHIC 117964
7 arvn-20240416_g5.jpg GRAPHIC 96106
8 arvn-20240416_g6.jpg GRAPHIC 462293
9 arvn-20240416_g7.jpg GRAPHIC 186303
  Complete submission text file 0001655759-24-000052.txt   3659904

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20240416.xsd EX-101.SCH 922
21 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20240416_htm.xml XML 85966
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38672 | Film No.: 24848776
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)